Global Event Calendar and Registration

Technical Report Portal

PDA/FDA Advanced Technologies for Virus Detection in the Evaluation of Biologicals Conference

Add Event to Calendar

Application and Challenges
November 13 – 14, 2013 | Bethesda North Marriott Hotel  | Bethesda, MD
Exhibition: November 13 – 14 | Courses: November 12

Advanced Notification - Sign up to receive an email when more information is available about this event!

Call for Posters Now Open

The 2013 PDA/FDA Advanced Technologies for Virus Detection in the Evaluation of Biologicals Program Planning Committee invite you to submit a scientific abstract for a one-day poster presentation at the PDA/FDA Advanced Technologies for Virus Detection in the Evaluation of Biologicals Conference, which will be held on November 13-14, 2013 in Bethesda, Maryland. Case studies are particularly desired. Commercial abstracts featuring promotion of products and services will not be considered.

Abstract Overview
Submit your Abstract

Submission Deadline: July 26, 2013 

This conference will present and discuss considerations for use of novel virus detection technologies for the characterization of biological materials used in the production of vaccines and recombinant, therapeutic products. There has been no known case of a human infection due to the presence of any adventitious virus in a biological product. However, adventitious agents have been detected in biological materials used in product manufacture. Most recently, porcine circovirus and vesivirus were found in cells used in the manufacture of a rotavirus vaccine and a therapeutic product, respectively. These findings emphasize the need for broad-spectrum and sensitive assays to detect adventitious viruses and other microbial agents in biological products. Advanced virus detection methods such as massively parallel or deep sequencing, broad range PCR with mass spectrometry, and virus microarrays have demonstrated success in identifying novel viruses in some research, biological, and clinical samples. However, there are a number of factors to consider for using these methods to characterize biological materials used in manufacture. Approaches to address some of the critical issues related to sample processing and bioinformatics will be presented. An expert panel including representatives from industry and regulatory agencies will discuss these novel detection assays, their strengths and limitations and how they can be used to enhance the characterization provided by conventional assays.

Learning Objectives

At the completion of this conference, you will be able to:

  • Describe the potential applications of the new methods in overall testing strategies
  • Discuss how advanced virus detection technologies might enhance current testing methods
  • Identify the challenges in implementing use of advanced technologies for virus detection in biologicals
  • Discuss use of new virus detection methods for characterization of biological materials in product manufacture

Who Should Attend

This conference will be of value to mid and senior level professionals from the pharmaceutical, biopharmaceutical biological industry, regulatory agencies, source material suppliers and biologics safety testing providers in the following areas:

  • Development of Pharmaceutical and Biopharmaceutical Products
  • Biotechnology
  • Vaccines
  • Manufacturing
  • Pathogen Safety Groups
  • Quality Assurance and Control
  • Formulation and Process Development
  • Risk Assessment
  • Regulatory

Contact

Conference inquiries:

Leon D. Lewis
Director, Programs and Meetings
Tel: +1 (301) 656-5900 ext. 149
Email: lewis@pda.org

Wanda Neal, CMP
Senior Vice President, Programs and Registration Services
Tel: +1 (301) 656-5900 ext. 111
Email: neal@pda.org

Registration inquiries:

Patresa Day
Manager, Registration and Customer Accounts
Tel: +1 (301) 656-5900 ext. 115
Email: day@pda.org

Exhibition inquiries:

David Hall
Vice President, Sales
Tel: +1 (301) 656-5900 ext. 160
Email: hall@pda.org

  Before September 3, 2013 September 3-October 3, 2013 After October 3, 2013
Member $1,695 $1,895 $2,095
Nonmember $1,944 $2,144 $2,344
Government/Health Authority Member $ 700 $ 700 $ 700
Government/Health Authority Nonmember* $ 800 $ 800 $ 800
Academic Member $ 700 $ 700 $ 700
Academic Nonmember* $ 800 $ 800 $ 800
Student Member $ 280 $ 280 $ 280
Student Nonmember* $ 310 $ 310 $ 310

All prices in US dollars.

* For this member type, online registration is not available must be faxed in.

Please note: In order to receive the prevailing registration rate, your registration(s) must be received by PDA by 5:00 p.m. ET on or before the date noted.

Please read PDA's confirmation, substitution, refund and photo release policies for this conference and course.

Group Registration Discount

Register 4 people from the same organization as a group (at the same time) for the conference and receive the 5th registration free. Other discounts cannot be applied.

Special Dietary Requirements

Please let us know if you have any special dietary requirement we may assist you with. Please contact Patresa Day at day@pda.org for help.

Please read: PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.
PDA/FDA Vaccines Conference

Bethesda North Marriott Hotel and Conference Center 
5701 Marinelli Road
Bethesda, MD 20852
Phone: +1 (301) 822-9200

Hotel website: http://www.marriott.com/hotels/travel/wasbn-bethesda-north-marriott-hotel-and-conference-center/

Rate: Single/Double:  $209.00, plus applicable state and local taxes.
Cut Off Date: Monday, October 21, 2013 (Rooms must be secured by this date in order to receive the PDA rate).  Rates are guaranteed until the PDA block of rooms are sold out on a first come basis. 

Hotel Accommodations

PDA/FDA Vaccines ConferenceTo make reservations at the Marriott Bethesda North Hotel and Conference Center, please call the Hotel at +1 (301) 822-9200 and reference the PDA/FDA Advanced Technologies for Virus Detection in the Evaluation of Biologicals Conference to receive the PDA group rate. Check in time is 4:00 p.m., and check out time is 12:00 noon.

Individual Cancellation

Please be aware that obtaining and canceling hotel reservations is the responsibility of the meeting registrant. Individuals will be responsible for payment of their own cancellation fees. The cancellation policy is 6 p.m. on the date of arrival otherwise specified on your reservation information.

Amenities

The Marriott Bethesda North Hotel & Conference Center is adjacent to the White Flint METRO Station on the RED line offering easy access to Rockville, Bethesda, Washington D.C. and Northern Virginia. All 220 guest rooms and suites provide high-speed Internet, upgraded Marriott Revive bedding, coffee makers, hair dryers, iron and an ironing board.

Travel

Area Airports
Reagan National Airport (DCA) is approximately 20 miles from the hotel and all major carriers service this airport. Two other airports in the vicinity are both serviced by all major carriers: Dulles International, 24 miles away, and Baltimore-Washington International, 34 miles away.

Ground Transportation PDA/FDA Vaccines Conference
Taxi fares from DCA are approximately $55 one way, not including tip, and will take about 30 minutes. One way taxi fares from Dulles is approximately $55 and from BWI about $75. 

Driving
Bethesda North Marriott is located on Marinelli Road off of Rockville Pike in Rockville.

Metro
The Bethesda North Marriott is located on the RED line at the White Flint Station.

Hotel Parking
$15 Self Parking

From: 
Email:  
To: 
Email:  
Subject: 
Message: